KalVista Pharmaceuticals, Inc.
Total Trades
184
Buys
8
Sells
92
Largest Trade
N/A
Insiders
9
Institutional Funds
118
Inst. Value
$1M+
Activist Filings
50
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $100K–$500K | 12K | $14.11 | Feb 22, 2024 |
| Palleiko Benjamin L | CFO, CBO | SELL | $100K–$500K | 23K | $14.11 | Feb 22, 2024 |
| Palleiko Benjamin L | CFO, CBO | EXERCISE | N/A | 51K | — | Feb 22, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 14K | $14.12 | Feb 22, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 31K | — | Feb 22, 2024 |
| Crockett Thomas Andrew | CEO | SELL | $100K–$500K | 25K | $14.11 | Feb 22, 2024 |
| Crockett Thomas Andrew | CEO | EXERCISE | N/A | 54K | — | Feb 22, 2024 |
| Palleiko Benjamin L | CFO, CBO | SELL | $500K+ | 41K | $15.01 | Feb 16, 2024 |
| Crockett Thomas Andrew | CEO | SELL | $500K+ | 58K | $15.01 | Feb 16, 2024 |
| Feener Edward P. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 28K | $15.01 | Feb 16, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $500K+ | 40K | $15.01 | Feb 16, 2024 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $1M+ | 86K | $14.62 | Feb 9, 2024 |
| Crockett Thomas Andrew | CEO | SELL | $100K–$500K | 10K | $16.22 | Feb 5, 2024 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $1M+ | 88K | $14.47 | Feb 1, 2024 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $1M+ | 92K | $14.05 | Jan 30, 2024 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $1M+ | 99K | $12.53 | Jan 25, 2024 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $1M+ | 144K | $12.55 | Jan 19, 2024 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $100K–$500K | 26K | $12.72 | Jan 17, 2024 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $1M+ | 519K | $12.46 | Dec 29, 2023 |
| Crockett Thomas Andrew | CEO | SELL | $100K–$500K | 30K | $12.02 | Dec 28, 2023 |
| Audhya Paul K. | Chief Medical Offi… | EXERCISE | N/A | 19K | — | Nov 21, 2023 |
| Audhya Paul K. | Chief Medical Offi… | SELL | $50K–$100K | 8K | $8.23 | Nov 21, 2023 |
| Feener Edward P. | Chief Scientific O… | SELL | $15K–$50K | 5K | $8.23 | Nov 21, 2023 |
| Feener Edward P. | Chief Scientific O… | EXERCISE | N/A | 11K | — | Nov 21, 2023 |
| Yea Christopher | Chief Development … | SELL | $50K–$100K | 7K | $8.23 | Nov 21, 2023 |
| Yea Christopher | Chief Development … | EXERCISE | N/A | 11K | — | Nov 21, 2023 |
| Palleiko Benjamin L | President | SELL | $100K–$500K | 13K | $8.23 | Nov 21, 2023 |
| Palleiko Benjamin L | President | EXERCISE | N/A | 30K | — | Nov 21, 2023 |
| Crockett Thomas Andrew | CEO | EXERCISE | N/A | 34K | — | Nov 21, 2023 |
| Crockett Thomas Andrew | CEO | SELL | $100K–$500K | 15K | $8.23 | Nov 21, 2023 |
| Cha Albert | Director | EXERCISE | $100K–$500K | 18K | $7.49 | Sep 13, 2023 |
| Cha Albert | Director | SELL | $100K–$500K | 18K | $10.50 | Sep 13, 2023 |
| Audhya Paul K. | Chief Medical Offi… | EXERCISE | N/A | 19K | — | Aug 22, 2023 |
| Audhya Paul K. | Chief Medical Offi… | SELL | $50K–$100K | 8K | $10.73 | Aug 22, 2023 |
| Feener Edward P. | Chief Scientific O… | EXERCISE | N/A | 11K | — | Aug 22, 2023 |
| Feener Edward P. | Chief Scientific O… | SELL | $50K–$100K | 5K | $10.73 | Aug 22, 2023 |
| Yea Christopher | Chief Development … | SELL | $50K–$100K | 7K | $10.73 | Aug 22, 2023 |
| Yea Christopher | Chief Development … | EXERCISE | N/A | 11K | — | Aug 22, 2023 |
| Palleiko Benjamin L | President | EXERCISE | N/A | 30K | — | Aug 22, 2023 |
| Palleiko Benjamin L | President | SELL | $100K–$500K | 13K | $10.73 | Aug 22, 2023 |
| Crockett Thomas Andrew | CEO | EXERCISE | N/A | 34K | — | Aug 22, 2023 |
| Crockett Thomas Andrew | CEO | SELL | $100K–$500K | 15K | $10.73 | Aug 22, 2023 |
| Yea Christopher | Chief Development … | EXERCISE | N/A | 4K | — | May 20, 2023 |
| Yea Christopher | Chief Development … | SELL | $15K–$50K | 3K | $10.14 | May 20, 2023 |
| Palleiko Benjamin L | President | EXERCISE | N/A | 9K | — | May 20, 2023 |
| Palleiko Benjamin L | President | SELL | $15K–$50K | 4K | $10.14 | May 20, 2023 |
| Feener Edward P. | Chief Scientific O… | EXERCISE | N/A | 4K | — | May 20, 2023 |
| Feener Edward P. | Chief Scientific O… | SELL | $15K–$50K | 2K | $10.14 | May 20, 2023 |
| Crockett Thomas Andrew | CEO | EXERCISE | N/A | 13K | — | May 20, 2023 |
| Crockett Thomas Andrew | CEO | SELL | $50K–$100K | 6K | $10.14 | May 20, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 118 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VR Adviser, LLC | 6.7M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 5.0M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 4.6M | $1M+ | SH |
| Capital World Investors | 2.8M | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.4M | $1M+ | SH |
| Point72 Asset Management, L.P. | 2.3M | $1M+ | SH |
| STATE STREET CORP | 1.9M | $1M+ | SH |
| EMERALD ADVISERS, LLC | 1.3M | $1M+ | SH |
| Octagon Capital Advisors LP | 1.3M | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.2M | $1M+ | SH |
| EMERALD MUTUAL FUND ADVISERS TRUST | 855K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 818K | $1M+ | SH |
| BARCLAYS PLC | 700K | $1M+ | SH |
| Squadron Capital Management LLC | 700K | $1M+ | SH |
| Freestone Grove Partners LP | 633K | $1M+ | SH |
| Spruce Street Capital LP | 388K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 382K | $1M+ | SH |
| Bank of New York Mellon Corp | 377K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 360K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 360K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Point72 Asset Management, L.P.
SC 13G/A · Jan 13, 2026
5.5%
2.8M shares
Point72 Asset Management, L.P.
SC 13G · Jan 12, 2026
4.9%
2.5M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Dec 30, 2025
5.1%
2.6M shares
SC 13G/A · Nov 14, 2025
1.5%
750K shares
SC 13G · Nov 10, 2025
5.0%
2.5M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Nov 4, 2025
6.9%
3.5M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Aug 20, 2025
4.8%
2.4M shares
SC 13G/A · May 15, 2025
9.9%
4.9M shares
SC 13G/A · May 13, 2025
6.4%
3.2M shares
SC 13G/A · Nov 14, 2024
10.0%
4.3M shares
Suvretta Capital Management, LLC
SC 13G/A · Nov 14, 2024
10.0%
4.3M shares
SC 13G · Nov 14, 2024
9.3%
4.0M shares
Capital World Investors 95-1411037
SC 13G · Nov 13, 2024
7.8%
3.4M shares
SC 13G/A · Nov 12, 2024
5.0%
2.2M shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
3.3%
1.4M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13D/A · Nov 7, 2024
4.9%
2.4M shares
SC 13G/A · Nov 4, 2024
5.0%
2.2M shares
SC 13D/A · Apr 1, 2024
3.2%
1.3M shares
SC 13G · Feb 26, 2024
6.9%
2.8M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13D/A · Feb 22, 2024
3.6%
1.5M shares
SC 13D/A · Feb 20, 2024
6.5%
2.7M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 15, 2024
14.0%
4.8M shares
SC 13G/A · Feb 14, 2024
10.0%
3.4M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2024
7.8%
2.7M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.2%
1.8M shares
Saturn V Capital Management LP
SC 13G · Feb 13, 2024
4.1%
1.4M shares
SC 13G · Jan 29, 2024
6.5%
2.2M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Dec 28, 2023
10.3%
3.6M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Dec 14, 2023
4.2%
1.5M shares
Suvretta Capital Management, LLC
SC 13G · Mar 10, 2023
5.3%
1.8M shares
SC 13G/A · Feb 14, 2023
3.1%
1.1M shares
SC 13G/A · Feb 14, 2023
9.4%
3.2M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 13, 2023
0.2%
83 shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2023
3.1%
1.1M shares
SC 13G/A · Jan 31, 2023
0.0%
0 shares
SC 13D · Jan 9, 2023
9.9%
3.4M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Jan 9, 2023
8.6%
2.9M shares
SC 13G/A · Jan 6, 2023
4.6%
1.6M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Dec 30, 2022
3.8%
1.3M shares
SC 13G/A · Aug 15, 2022
0.0%
0 shares
SC 13G · May 26, 2022
5.7%
1.4M shares
SC 13G · May 18, 2022
5.2%
1.3M shares
SC 13G/A · Feb 14, 2022
0.2%
37K shares
SC 13G/A · Feb 14, 2022
7.9%
1.9M shares
Eventide Asset Management, LLC
SC 13G/A · Feb 14, 2022
0.6%
139K shares
SC 13G/A · Feb 14, 2022
6.1%
1.5M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 11, 2022
7.1%
1.7M shares
SC 13G/A · Feb 11, 2022
4.8%
1.2M shares